ClinVar Miner

Submissions for variant NM_000163.5(GHR):c.184G>A (p.Glu62Lys)

gnomAD frequency: 0.00001  dbSNP: rs121909361
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004766992 SCV005381114 likely pathogenic Growth hormone insensitivity syndrome 2024-08-14 criteria provided, single submitter clinical testing Variant summary: GHR c.184G>A (p.Glu62Lys) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251356 control chromosomes (gnomAD). c.184G>A has been reported in the literature in an individuals affected with partial growth hormone insensitivity and short stature (Goddard_1995). These data do not allow any conclusion about variant significance. This publication reports experimental evidence evaluating an impact on protein function, finding that the variant resulted in severely impaired GH binding. The following publication has been ascertained in the context of this evaluation (PMID: 7565946). ClinVar contains an entry for this variant (Variation ID: 8636). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV005089214 SCV005834469 uncertain significance not provided 2024-11-27 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 62 of the GHR protein (p.Glu62Lys). This variant is present in population databases (rs121909361, gnomAD 0.003%). This missense change has been observed in individual(s) with clinical features of autosomal dominant growth hormone insensitivity syndrome (PMID: 7565946). This variant is also known as Glu44Lys. ClinVar contains an entry for this variant (Variation ID: 8636). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GHR protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
OMIM RCV000009168 SCV000029385 pathogenic Short stature due to partial GHR deficiency 1995-10-26 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.